Table 1.
General characteristics of the patients’ population (n 102).
Table 2.
Echocardiographic data (n 102).
Table 3.
Univariate regression analysis.
Fig 1.
Kaplan-Meier curves according to PAH risk groups applying the strategy of COMPERA registry.
Fig 2.
Kaplan-Meier curves according to PAH risk groups applying the invasive (a) and non-invasive (b) strategy of FPHN registry.
Table 4.
Characteristics of the population according to TAPSE/TRV ratio values.
Fig 3.
ROC analysis of TAPSE, TAPSE/sPAP, and TAPSE/TRV according to the optimal cut-point calculated with Contal and O’Quingley analysis.